Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Framingham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
KalVista Pharmaceuticals, Inc. has filed 884 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 676-700 of 882 matching filings.

Per page
25
Current page
28
4

FORM 4

Filing date
29 Sep 2017
Reporting date
27 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
29 Sep 2017
Reporting date
27 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36830

FORM 8-K

Filing date
28 Sep 2017
Reporting date
27 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88797

SC 13D/A

Filing date
22 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
18 Sep 2017
Reporting date
13 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Sep 2017
Reporting date
13 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36830

8-K

Filing date
14 Sep 2017
Reporting date
14 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36830

DEF 14A

Filing date
25 Aug 2017
Reporting date
27 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36830

FORM 8-K

Filing date
25 Aug 2017
Reporting date
21 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36830

FORM 8-K

Filing date
13 Jul 2017
Reporting date
13 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-217009

FILED PURSUANT TO RULE 424(B)(5)

Filing date
13 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36830

8-K

Filing date
30 May 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 May 2017
Reporting date
25 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 May 2017
Reporting date
25 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 May 2017
Reporting date
25 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 May 2017
Reporting date
25 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-217009

EFFECT filing

Filing date
28 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-217009

AMENDMENT NO. 1 TO FORM S-3

Filing date
27 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
24 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-217009

FORM S-3

Filing date
29 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .